Cargando…

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

BACKGROUND: To investigate age-related severity, patterns of retinal structural damage, and functional visual recovery in pediatric and adult cohorts of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) optic neuritis (ON). METHODS: All MOGAD patients from the 5 participating c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havla, Joachim, Pakeerathan, Thivya, Schwake, Carolin, Bennett, Jeffrey L., Kleiter, Ingo, Felipe-Rucián, Ana, Joachim, Stephanie C., Lotz-Havla, Amelie S., Kümpfel, Tania, Krumbholz, Markus, Wendel, Eva M., Reindl, Markus, Thiels, Charlotte, Lücke, Thomas, Hellwig, Kerstin, Gold, Ralf, Rostasy, Kevin, Ayzenberg, Ilya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164737/ https://www.ncbi.nlm.nih.gov/pubmed/34051804 http://dx.doi.org/10.1186/s12974-021-02160-9

Ejemplares similares

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode
por: Pakeerathan, T., et al.
Publicado: (2022)

Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
por: Havla, Joachim, et al.
Publicado: (2013)

Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD)
por: Gernert, Jonathan A., et al.
Publicado: (2022)

Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
por: Reindl, Markus, et al.
Publicado: (2023)

Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis
por: Gernert, Jonathan A., et al.
Publicado: (2023)

Therapy challenges for NMOSD in a patient with HIV
por: Engels, Daniel, et al.
Publicado: (2023)

Optical Coherence Tomography: Retinal Imaging Contributes to the Understanding of Brain Pathology in Classical Galactosemia
por: Lotz-Havla, Amelie S., et al.
Publicado: (2023)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Retinal axonal degeneration in Niemann–Pick type C disease
por: Havla, Joachim, et al.
Publicado: (2020)

Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
por: Havla, Joachim, et al.
Publicado: (2022)

Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome
por: Schulze, Hannah, et al.
Publicado: (2022)

Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
por: Mulazzani, Elisabeth, et al.
Publicado: (2020)

Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency
por: Lotz-Havla, Amelie S., et al.
Publicado: (2021)

Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
por: Schlüter, Miriam, et al.
Publicado: (2021)

SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
por: Eisenhut, Katharina, et al.
Publicado: (2021)

Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021
por: Richter, Daniel, et al.
Publicado: (2023)

Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?
por: Gernert, J.A., et al.
Publicado: (2022)

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody–Seropositive Patients
por: Ayzenberg, Ilya, et al.
Publicado: (2021)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
por: Oertel, Frederike C., et al.
Publicado: (2019)

Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies
por: Mortazavi, Matin, et al.
Publicado: (2021)

Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
por: Hümmert, Martin W, et al.
Publicado: (2023)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
por: Schuh, E, et al.
Publicado: (2015)

Conserved targeting information in mammalian and fungal peroxisomal tail-anchored proteins
por: Buentzel, Judith, et al.
Publicado: (2015)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

Newborn screening for carnitine transporter defect in Bavaria and the long-term follow-up of the identified newborns and mothers: Assessing the benefit and possible harm based on 19 ½ years of experience
por: Schiergens, Katharina A., et al.
Publicado: (2021)

Relapse-independent multiple sclerosis progression under natalizumab
por: Graf, Jonas, et al.
Publicado: (2021)

Clinical and neuroimaging findings in MOGAD–MRI and OCT
por: Bartels, Frederik, et al.
Publicado: (2021)

Attack phenotypes and disease course in pediatric MOGAD
por: Santoro, Jonathan D., et al.
Publicado: (2023)

Editorial: MOGAD, current knowledge and future trends
por: Siritho, Sasitorn, et al.
Publicado: (2023)

Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
por: Klotz, Luisa, et al.
Publicado: (2019)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
por: Krumbholz, Markus, et al.
Publicado: (2015)

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)

NMOSD IgG Impact Retinal Cells in Murine Retinal Explants
por: Wolf, Hannah Nora, et al.
Publicado: (2023)

Case report: Anti septin-5-encephalitis as a treatable cause of cerebellar ataxia and psychiatric symptoms
por: Wischmann, Johannes, et al.
Publicado: (2023)

How Much Does AMH Really Vary in Normal Women?
por: La Marca, Antonio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lekk46c59m95r0sbooq9p1la5m